SMA Europe 2020
The recent development of new therapies for SMA is changing the landscape of our disease in such a way that there is an increasing need to get the research and clinical community together to share and learn. It is of utmost importance for patients to ensure that new findings about the disease are communicated: from new phenotypes and modifier agents, to predictive methods for patient responses, to innovation in care. All of this has a huge impact on the future of the patients and their families.
2nd International Scientific & Clinical Congress on Spinal Muscular Atrophy
Organisation, gestion, secrétariat des participants, inscriptions, site internet, abstracts, restauration, dîner de gala, dîner VIP, suivi et facturation des sponsors, mise en place de l’exposition, secrétariat des invités